Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Arca Biopharma Inc (NQ: ABIO )

3.580 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,814
Open 3.580
Bid (Size) 3.650 (1)
Ask (Size) 3.880 (45)
Prev. Close 3.580
Today's Range 3.580 - 3.580
52wk Range 1.560 - 4.490
Shares Outstanding 14,410,143
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why ARCA Biopharma Shares Are Trading Higher Today
ARCA Biopharma shares are trading higher by 8.1% Monday morning. The company announced a special dividend of $1.59 per share. 
Via Benzinga
Estée Lauder, Palo Alto Networks And 3 Stocks To Watch Heading Into Monday
Via Benzinga

Performance

YTD
+113.35%
+113.35%
1 Month
+9.82%
+9.82%
3 Month
+9.82%
+9.82%
6 Month
+118.29%
+118.29%
1 Year
+74.63%
+74.63%

More News

Read More
Anixa Biosciences And 3 Other Stocks Under $5 Insiders Are Buying
Via Benzinga
Citizens And 4 Other Stocks Under $5 Insiders Are Buying
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
ABIO Stock Earnings: ARCA biopharma Reported Results for Q1 2024
Via InvestorPlace
Why Is ARCA Biopharma (ABIO) Stock Up 85% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
3 Short-Squeeze Stocks Ready to Soar on Roaring Kitty Rally
Via InvestorPlace
GameStop Trader 'Roaring Kitty' Sparks Wall Street Rally In Heavily Shorted Stocks: What You Need To Know Right Now
Via Benzinga
ARCA BIOPHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO
From Kahn Swick & Foti, LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN), ARCA biopharma, Inc. (Nasdaq - ABIO)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN), ARCA biopharma, Inc. (Nasdaq - ABIO)
From Brodsky & Smith LLC
Via GlobeNewswire
ARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO
From Kahn Swick & Foti, LLC
Via Business Wire
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Flora Growth Shares Are Trading Lower By Around 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Nasdaq Gains 75 Points; Acuity Brands Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Moves Higher; ISM Services PMI Falls In March
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Exposures Glyphosate
ARCA Biopharma Inc. (NASDAQ: ABIO) is One of Wednesday Morning’s Most Active Stocks
Via Investor Brand Network
Small-Cap ARCA Biopharma Stock Soars On Merger Pact: The Details
Via Benzinga
US Stocks Edge Lower; Private Employment Tops Views
Via Benzinga
Topics Stocks
Exposures US Equities
ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.